SCHEMBL19714573

SCHEMBL19714573

COc1cccc(NC(=O)Cn2c(NCc3ccccc3)nc3ccccc32)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ TP53 P04637 4/20 0.57
▸ MAPT P10636 2/20 0.57
▸ RXFP1 Q9HBX9 1/20 0.57
▸ PIN1 Q13526 1/20 0.56
▸ TSHR P16473 2/20 0.56
▸ RAB9A P51151 2/20 0.55
▸ CBX7 O95931 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ CDYL2 Q8N8U2 1/20 0.55
▸ CDYL Q9Y232 1/20 0.55
▸ CDY1; CDY1B Q9Y6F8 1/20 0.55
▸ LMNA P02545 1/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ NTRK1 P04629 1/20 0.53
▸ NTRK2 Q16620 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19714625 0.89 TP53 (0.62) TP53MAPTRAB9ASMN1; SMN2LMNA
SCHEMBL19714580 0.87 MAPT (0.64) USP2MAPTPIN1TSHRRAB9A
SCHEMBL19714443 0.83 LMNA (0.60) USP2TP53MAPTRXFP1TSHR
SCHEMBL19714466 0.81 KMT2A (0.65) USP2TP53MAPTTSHRRAB9A
SCHEMBL19714641 0.80 ALDH1A1 (0.63) USP2MAPTTSHRRAB9ARECQL
SCHEMBL17824313 0.80 MMP2 (0.54) USP2MAPTTSHRRAB9ASMN1; SMN2
SCHEMBL19714594 0.79 KMT2A (0.53) USP2MAPTTSHRRAB9ARECQL
SCHEMBL31134125 0.78 PIN1 (0.68) USP2HSD17B10TP53MAPTPIN1
SCHEMBL19714285 0.78 POLB (0.59) HSD17B10TP53MAPTTSHRRAB9A
SCHEMBL17824291 0.78 LMNA (0.50) USP2MAPTTSHRRAB9ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS HERIOT-WATT UNIVERSITY (GB) 2017-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362184-A1 PRO-SURVIVAL COMPOUNDS MCL1, MKI67, MORF4L1 USP2 2298/4885HSD17B10 2109/4885TP53 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback